Stafford Kristin
SEC insider (Form 3/4/5 filer). CIK 0001970438. Director at NovoCure Ltd (NVCR) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in WAYNE, PA.
Companies Stafford Kristin has filed insider reports for
- NovoCure Ltd (NVCR): Director
- Zymeworks Inc. (ZYME): Officer, EVP, Chief Financial Officer
Stafford Kristin
CIK: 0001970438
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (28.6%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (71.4%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 3, 2026NVCR
NovoCure Ltd
AwardDirect11.6K shares- - Jun 2, 2026NVCR
NovoCure Ltd
SaleDirect2.9K shares at avg. $15.77$46K - Apr 6, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
178K shares- - Apr 6, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
119K shares- - Apr 6, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
50K shares- - Jun 4, 2025NVCR
NovoCure Ltd
AwardDirect11.2K shares- - Jun 3, 2025NVCR
NovoCure Ltd
SaleDirect999 shares at avg. $17.28$17K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  NVCR NovoCure Ltd | Award | 11,610 | - | $0 | Direct |
| Jun 2, 2026 | NVCR NovoCure Ltd | Sale | 2,945 | $15.77 | $46,445 | Direct |
| Apr 6, 2026 |  ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 178,000 | - | - | Direct |
| Apr 6, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 119,000 | - | - | Direct |
| Apr 6, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 50,000 | - | - | Direct |
| Jun 4, 2025 | NVCR NovoCure Ltd | Award | 11,215 | - | - | Direct |
| Jun 3, 2025 | NVCR NovoCure Ltd | Sale | 999 | $17.28 | $17,259 | Direct |
1-7 of 7 transactions